{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:13:43Z","timestamp":1792462423844,"version":"4.5.0"},"reference-count":100,"publisher":"Croatian Society for Medical Biochemistry and Laboratory Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochem. med. (Online)"],"published-print":{"date-parts":[[2020,10,15]]},"abstract":"<jats:p>Diabetic retinopathy (DR) is one of the most common microvascular complications of diabetes mellitus (DM) and a leading cause of blindness in working-age adults in developed countries. Numerous investigations have recognised inflammation and angiogenesis as important factors in the development of this complication of diabetes. Current methods of DR treatment are predominantly used at advanced stages of the disease and could be associated with serious side effects. Therefore, new diagnostic methods are needed in order to identify the initial stages of DR as well as monitoring the effects of applied therapy. Biochemical biomarkers are molecules found in blood or other biological fluid and tissue that indicate the existence of an abnormal condition or disease. They could be a valuable tool in detecting early stages of DR, identifying patients most susceptible to retinopathy progression and monitoring treatment outcomes. Biomarkers related to DR can be measured in the blood, retina, vitreous, aqueous humour and recently in tears. As the retina represents a small part of total body mass, a circulating biomarker for DR needs to be highly specific. Local biomarkers are more reliable as indicators of the retinal pathology; however, obtaining a sample of aqueous humour, vitreous or retina is an invasive procedure with potential serious complications. As a non-invasive novel method, tear analysis offers a promising direction in further research for DR biomarker detection. The aim of this paper is to review systemic and local inflammatory and angiogenic biomarkers relevant to this sight threatening diabetic complication.<\/jats:p>","DOI":"10.11613\/bm.2020.030502","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T07:38:44Z","timestamp":1596181124000},"page":"385-399","source":"Crossref","is-referenced-by-count":155,"title":["Inflammatory and angiogenic biomarkers in diabetic retinopathy"],"prefix":"10.11613","volume":"30","author":[{"given":"Snje\u017eana","family":"Ka\u0161telan","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Clinical Hospital Dubrava, Zagreb, Croatia; School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Ore\u0161kovi\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Zagreb, Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Bi\u0161\u0107an","sequence":"additional","affiliation":[{"name":"Augenzentrum M\u00fchldorf, \u00dcber\u00f6rtliche Gemeinschaftspraxis, M\u00fchldorf am Inn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Ka\u0161telan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, General Hospital Dubrovnik, Dubrovnik, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonela","family":"Gverovi\u0107 Antunica","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, General Hospital Dubrovnik, Dubrovnik, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4885","published-online":{"date-parts":[[2020,10,12]]},"reference":[{"key":"key20200731033836_r1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/bjophthalmol-2013-304017","article-title":"Prevalence of diabetic retinopathy within a national diabetic retinopathy screening service.","volume":"99","author":"Thomas","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"key20200731033836_r2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0161-6420(03)00475-5","article-title":"Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales.","volume":"110","author":"Wilkinson","year":"2003","journal-title":"Ophthalmology"},{"key":"key20200731033836_r3","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.2337\/diacare.27.2007.S84","article-title":"Retinopathy in Diabetes.","volume":"27","author":"Fong","year":"2004","journal-title":"Diabetes Care"},{"key":"key20200731033836_r4","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1477-7827-8-124","article-title":"Maternal immune system adaptation to pregnancy - a potential influence on the course of diabetic retinopathy.","volume":"8","author":"Ka\u0161telan","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"key20200731033836_r5","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/213130","article-title":"Inflammation and pharmacological treatment in diabetic retinopathy.","volume":"2013","author":"Ka\u0161telan","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r6","first-page":"7113","article-title":"Association of serum inflammatory markers and diabetic retinopathy: a review of literature.","volume":"22","author":"Gouliopoulos","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"key20200731033836_r7","first-page":"65","article-title":"The association between the HLA system and retinopathy development in patients with type 1 diabetes mellitus.","volume":"37","author":"Ka\u0161telan","year":"2013","journal-title":"Coll Antropol"},{"key":"key20200731033836_r8","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/436329","article-title":"Body mass index: a risk factor for retinopathy in type 2 diabetic patients.","volume":"2013","author":"Ka\u0161telan","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r9","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/582060","article-title":"Diabetic Retinopathy: Vascular and Inflammatory Disease.","volume":"2015","author":"Semeraro","year":"2015","journal-title":"J Diabetes Res"},{"key":"key20200731033836_r10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/ijms19010110","article-title":"The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.","volume":"19","author":"Altmann","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200731033836_r11","article-title":"Current Advances in Pharmacotherapy and Technology for Diabetic Retinopathy: A Systematic Review.","volume":"2018","author":"Lu","year":"2018","journal-title":"J Ophthalmol"},{"key":"key20200731033836_r12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3390\/ijms19040942","article-title":"Role of Inflammation in Diabetic Retinopathy.","volume":"19","author":"R\u00fcbsam","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200731033836_r13","first-page":"51","article-title":"The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy.","volume":"37","author":"Tomi\u0107","year":"2013","journal-title":"Coll Antropol"},{"key":"key20200731033836_r14","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/14712598.2018.1545836","article-title":"Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies.","volume":"18","author":"Whitehead","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"key20200731033836_r15","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ijms19061816","article-title":"Diabetic Retinopathy: Pathophysiology and Treatments.","volume":"19","author":"Wang","year":"2018","journal-title":"Int J Mol Sci"},{"key":"key20200731033836_r16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"National Institutes of Health Director\u2019s Initiative on Biomarkers and Surrogate Endpoints. Biomarkers and surrogate end points: preferred definitions and conceptual frameworks.","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"key20200731033836_r17","doi-asserted-by":"crossref","first-page":"BIO68","DOI":"10.1167\/iovs.17-21769","article-title":"Local and Systemic Inflammatory Biomarkers of Diabetic Retinopathy: An Integrative Approach.","volume":"58","author":"Vujosevic","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r18","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/jcb.25575","article-title":"Angiogenesis and Inflammation Crosstalk in Diabetic Retinopathy.","volume":"117","author":"Capit\u00e3o","year":"2016","journal-title":"J Cell Biochem"},{"key":"key20200731033836_r19","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/818671","article-title":"Inflammation, haemostatic disturbance, and obesity: possible link to pathogenesis of diabetic retinopathy in type 2 diabetes.","volume":"2013","author":"Tomi\u0107","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/sj\/eye\/6700095","article-title":"Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.","volume":"16","author":"Doganay","year":"2002","journal-title":"Eye (Lond)"},{"key":"key20200731033836_r21","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00417-011-1905-4","article-title":"IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients.","volume":"250","author":"Gverovi\u0107 Antunica","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key20200731033836_r22","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/IAE.0b013e31816576d5","article-title":"Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales\u2019 disease.","volume":"28","author":"Murugeswari","year":"2008","journal-title":"Retina"},{"key":"key20200731033836_r23","first-page":"637","article-title":"Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients.","volume":"14","author":"Maier","year":"2008","journal-title":"Mol Vis"},{"key":"key20200731033836_r24","doi-asserted-by":"crossref","first-page":"4295","DOI":"10.1167\/iovs.04-1057","article-title":"Serum inflammatory markers in diabetic retinopathy.","volume":"46","author":"Meleth","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r25","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1056-8727(01)00155-6","article-title":"Inflammatory cytokines in vitreous fluid and serum of patients with diabetic vitreoretinopathy.","volume":"15","author":"Yuuki","year":"2001","journal-title":"J Diabetes Complications"},{"key":"key20200731033836_r26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40942-019-0179-6","article-title":"Serum Vascular Endothelial Growth Factor Is a Biomolecular Biomarker of Severity of Diabetic Retinopathy.","volume":"5","author":"Ahuja","year":"2019","journal-title":"Int J Retina Vitreous"},{"key":"key20200731033836_r27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12886-017-0572-6","article-title":"Assessment of Biomarkers Using Multiplex Assays in Aqueous Humor of Patients with Diabetic Retinopathy.","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Ophthalmol"},{"key":"key20200731033836_r28","first-page":"1734","article-title":"Study of 27 aqueous humor cytokines in patients with type 2 diabetes with or without retinopathy.","volume":"19","author":"Dong","year":"2013","journal-title":"Mol Vis"},{"key":"key20200731033836_r29","first-page":"2931","article-title":"Changes to Tear Cytokines of Type 2 Diabetic Patients with or Without Retinopathy.","volume":"16","author":"Liu","year":"2010","journal-title":"Mol Vis"},{"key":"key20200731033836_r30","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/OPX.0000000000001456","article-title":"Total Protein Concentration and Tumor Necrosis Factor \u03b1 in Tears of Nonproliferative Diabetic Retinopathy.","volume":"96","author":"Amil-Bangsa","year":"2019","journal-title":"Optom Vis Sci"},{"key":"key20200731033836_r31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.5935\/0004-2749.20190055","article-title":"Intravitreal Neurodegenerative and Inflammatory Mediators in Proliferative Diabetic Retinopathy.","volume":"82","author":"Mallmann","year":"2019","journal-title":"Arq Bras Oftalmol"},{"key":"key20200731033836_r32","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8546423","article-title":"Levels of Inflammatory Cytokines IL-1\u03b2, IL-6, IL-8, IL-17A, and TNF-\u03b1 in Aqueous Humour of Patients with Diabetic Retinopathy.","volume":"2018","author":"Feng","year":"2018","journal-title":"J Diabetes Res"},{"key":"key20200731033836_r33","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajo.2006.07.032","article-title":"Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.","volume":"143","author":"Petrovic","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key20200731033836_r34","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9402198","article-title":"Association between Aqueous Cytokines and Diabetic Retinopathy Stage.","volume":"2017","author":"Wu","year":"2017","journal-title":"J Ophthalmol"},{"key":"key20200731033836_r35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/147323001003800111","article-title":"Serum Retinol-Binding Protein 4 Levels in Patients with Diabetic Retinopathy.","volume":"38","author":"Li","year":"2010","journal-title":"J Int Med Res"},{"key":"key20200731033836_r36","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1167\/iovs.17-21973","article-title":"Assessment of Neurotrophins and Inflammatory Mediators in Vitreous of Patients with Diabetic Retinopathy.","volume":"58","author":"Boss","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r37","first-page":"1649","article-title":"Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.","volume":"41","author":"Ishida","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r38","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00894-017-3442-5","article-title":"The Profile of Angiogenic Factors in Vitreous Humor of the Patients with Proliferative Diabetic Retinopathy.","volume":"17","author":"Yu","year":"2017","journal-title":"Curr Mol Med"},{"key":"key20200731033836_r39","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2337\/diacare.25.12.2352","article-title":"Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.","volume":"25","author":"Mitamura","year":"2002","journal-title":"Diabetes Care"},{"key":"key20200731033836_r40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/157339907779802139","article-title":"Leukocytes in diabetic retinopathy.","volume":"3","author":"Chibber","year":"2007","journal-title":"Curr Diabetes Rev"},{"key":"key20200731033836_r41","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0002-9440(10)64869-9","article-title":"Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.","volume":"160","author":"Joussen","year":"2002","journal-title":"Am J Pathol"},{"key":"key20200731033836_r42","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10787-019-00647-9","article-title":"Pericytes, inflammation and diabetic retinopathy.","volume":"28","author":"Spencer","year":"2020","journal-title":"Inflammopharmacology"},{"key":"key20200731033836_r43","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2016.08.001","article-title":"The importance of glial cells in the homeostasis of the retinal microenvironment and their pivotal role in the course of diabetic retinopathy.","volume":"162","author":"Sorrentino","year":"2016","journal-title":"Life Sci"},{"key":"key20200731033836_r44","first-page":"495","article-title":"Molecular mechanism and clinical applications of angiogenesis.","volume":"88","author":"Carmeliet","year":"2009","journal-title":"Journal of Genetic J Genet."},{"key":"key20200731033836_r45","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.preteyeres.2015.04.003","article-title":"Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.","volume":"48","author":"Sim\u00f3","year":"2015","journal-title":"Prog Retin Eye Res"},{"key":"key20200731033836_r46","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/872978","article-title":"Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.","volume":"2012","author":"Sim\u00f3-Servat","year":"2012","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r47","first-page":"40","article-title":"Review of Biomarkers in Ocular Matrices","volume":"36","author":"Tamhane","year":"2019","journal-title":"Challenges and Opportunities Pharm Res."},{"key":"key20200731033836_r48","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1900\/RDS.2015.12.159","article-title":"Biomarkers in Diabetic Retinopathy.","volume":"12","author":"Jenkins","year":"2015","journal-title":"Rev Diabet Stud"},{"key":"key20200731033836_r49","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0034-1372594","article-title":"Markers of the progression of complications in patients with type 2 diabetes: a one-year longitudinal study.","volume":"122","author":"Preciado-Puga","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key20200731033836_r50","doi-asserted-by":"crossref","first-page":"92196","DOI":"10.1155\/2007\/92196","article-title":"Serum TNF-alpha level predicts nonproliferative diabetic retinopathy in children.","volume":"2007","author":"Zorena","year":"2007","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r51","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/09273948.2015.1034804","article-title":"Serum and aqueous concentrations of inflammatory markers in diabetic macular edema.","volume":"24","author":"Kocabora","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"key20200731033836_r52","first-page":"1005","article-title":"Increased levels of IL-6, sIL-6R, and sgp130 in the aqueous humor and serum of patients with diabetic retinopathy.","volume":"22","author":"Chen","year":"2016","journal-title":"Mol Vis"},{"key":"key20200731033836_r53","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/629529","article-title":"TNF-alpha levels in tears: a novel biomarker to assess the degree of diabetic retinopathy.","volume":"2013","author":"Costagliola","year":"2013","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221481","article-title":"Evaluation of vascular endothelial growth factor levels in tears and serum among diabetic patients.","volume":"14","author":"Ang","year":"2019","journal-title":"PLoS One"},{"key":"key20200731033836_r55","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"key20200731033836_r56","first-page":"456","article-title":"Investigation of the human tear film proteome using multiple proteomic approaches.","volume":"14","author":"Green-Church","year":"2008","journal-title":"Mol Vis"},{"key":"key20200731033836_r57","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/978-1-4615-2417-5_52","article-title":"Tear protein composition and the effects of stimulus.","volume":"350","author":"Fullard","year":"1994","journal-title":"Adv Exp Med Biol"},{"key":"key20200731033836_r58","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/863418","article-title":"Vitreous Analysis in the Management of Uveitis.","volume":"2012","author":"Damato","year":"2012","journal-title":"Mediators Inflamm"},{"key":"key20200731033836_r59","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/eye.2017.285","article-title":"A novel and less invasive technique to assess cytokine profile of vitreous in patients of diabetic macular oedema.","volume":"32","author":"Srividya","year":"2018","journal-title":"Eye (Lond)"},{"key":"key20200731033836_r60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144406","article-title":"Relationship between C-Reactive Protein Level and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.","volume":"10","author":"Song","year":"2015","journal-title":"PLoS One"},{"key":"key20200731033836_r61","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.2337\/db09-1606","article-title":"TNF-\u03b1 signals through PKC\u03b6\/NF-\u03ba\u03b2 to alter the tight junction complex and increase retinal endothelial cell permeability.","volume":"59","author":"Aveleira","year":"2010","journal-title":"Diabetes"},{"key":"key20200731033836_r62","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/sj.eye.6702138","article-title":"Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy.","volume":"20","author":"Demircan","year":"2006","journal-title":"Eye (Lond)"},{"key":"key20200731033836_r63","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/S0161-6420(03)00568-2","article-title":"Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.","volume":"110","author":"Funatsu","year":"2003","journal-title":"Ophthalmology"},{"key":"key20200731033836_r64","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00281-019-00750-7","article-title":"The role of inflammation in diabetic eye disease.","volume":"41","author":"Mesquida","year":"2019","journal-title":"Semin Immunopathol"},{"key":"key20200731033836_r65","first-page":"44","article-title":"Serum inflammatory cytokines IL-1beta, IL-6, TNF-alpha and VEGF have influence on the development of diabetic retinopathy.","volume":"53","author":"Koleva-Georgieva","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"key":"key20200731033836_r66","first-page":"1829","article-title":"High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy.","volume":"17","author":"El-Asrar","year":"2011","journal-title":"Mol Vis"},{"key":"key20200731033836_r67","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.cyto.2009.11.004","article-title":"Roles of endothelin-1 and selected proinflammatory cytokines in the pathogenesis of proliferative diabetic retinopathy: Analysis of vitreous samples.","volume":"49","author":"Adamiec-Mroczek","year":"2010","journal-title":"Cytokine"},{"key":"key20200731033836_r68","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/IAE.0000000000001210","article-title":"Aqueous humor cytokine levels as biomarkers of disease severity in diabetic macular edema.","volume":"37","author":"Hillier","year":"2017","journal-title":"Retina"},{"key":"key20200731033836_r69","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1167\/iovs.13-12212","article-title":"Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.","volume":"54","author":"Roy","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r70","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1167\/iovs.12-9857","article-title":"Soluble vascular adhesion protein-1 accumulates in proliferative diabetic retinopathy.","volume":"53","author":"Murata","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20200731033836_r71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1055\/s-0031-1295491","article-title":"The metabolic role of retinol binding protein 4: an update.","volume":"44","author":"Christou","year":"2012","journal-title":"Horm Metab Res"},{"key":"key20200731033836_r72","doi-asserted-by":"crossref","first-page":"861","DOI":"10.4158\/EP14558.OR","article-title":"Altered circulating levels of retinol binding protein 4 and transthyretin in relation to insulin resistance, obesity, and glucose intolerance in Asian Indians.","volume":"21","author":"Pandey","year":"2015","journal-title":"Endocr Pract"},{"key":"key20200731033836_r73","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3945\/jn.113.189860","article-title":"Elevated plasma retinol-binding protein 4 is associated with increased risk of type 2 diabetes in middle-aged and elderly Chinese adults.","volume":"144","author":"Sun","year":"2014","journal-title":"J Nutr"},{"key":"key20200731033836_r74","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1210\/jc.2006-2712","article-title":"Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation.","volume":"92","author":"Balagopal","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key20200731033836_r75","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0021-5155(01)00452-X","article-title":"Plasma level of interleukin-6 is an indicator for predicting diabetic macular edema.","volume":"46","author":"Shimizu","year":"2002","journal-title":"Jpn J Ophthalmol"},{"key":"key20200731033836_r76","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/279037","article-title":"Leukocyte Adhesion Molecules in Diabetic Retinopathy.","volume":"2012","author":"Noda","year":"2012","journal-title":"J Ophthalmol"},{"key":"key20200731033836_r77","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1128\/MCB.00181-15","article-title":"Transgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism.","volume":"35","author":"Du","year":"2015","journal-title":"Mol Cell Biol"},{"key":"key20200731033836_r78","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181100","article-title":"Elevated RBP4 plasma levels were associated with diabetic retinopathy in type 2 diabetes.","volume":"38","author":"Li","year":"2018","journal-title":"Biosci Rep"},{"key":"key20200731033836_r79","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.preteyeres.2008.09.002","article-title":"Vascular endothelial growth factor and diabetic complications.","volume":"27","author":"Wirostko","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"key20200731033836_r80","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors.","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"key20200731033836_r81","first-page":"155","article-title":"Interleukina-12, naczyniowy czynnik wzrostu \u015br\u00f3db\u0142onka oraz czynnik martwicy nowotworu-alpha w procesie neoangiogenezy u dzieci z retinopatia cukrzycowa.","volume":"109","author":"Zorena","year":"2007","journal-title":"Klin Oczna"},{"key":"key20200731033836_r82","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2337\/diacare.25.12.2352","article-title":"Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.","volume":"25","author":"Mitamura","year":"2002","journal-title":"Diabetes Care"},{"key":"key20200731033836_r83","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/bjo.81.10.919","article-title":"Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes.","volume":"81","author":"Chen","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"key20200731033836_r84","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/9401628","article-title":"Serum Vascular Endothelial Growth Factor Levels Correlate with Severity of Retinopathy in Diabetic Patients: A Systematic Review and Meta-Analysis.","volume":"2019","author":"Zhou","year":"2019","journal-title":"Dis Markers"},{"key":"key20200731033836_r85","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/424783","article-title":"The Measurement of Intraocular Biomarkers in Various Stages of Proliferative Diabetic Retinopathy Using Multiplex xMAP Technology.","volume":"2015","author":"Rusnak","year":"2015","journal-title":"J Ophthalmol"},{"key":"key20200731033836_r86","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1076\/ceyr.22.2.140.5528","article-title":"Intravitreal VEGF and bFGF produce florid retinal neovascularization and hemorrhage in the rabbit.","volume":"22","author":"Wong","year":"2001","journal-title":"Curr Eye Res"},{"key":"key20200731033836_r87","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/jcs.115.12.2559","article-title":"Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.","volume":"115","author":"Odorisio","year":"2002","journal-title":"J Cell Sci"},{"key":"key20200731033836_r88","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/aos.13325","article-title":"Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases.","volume":"96","author":"Nguyen","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"key20200731033836_r89","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/B978-0-12-386471-0.00010-9","article-title":"Assays for the antiangiogenic and neurotrophic serpin pigment epithelium-derived factor.","volume":"499","author":"Subramanian","year":"2011","journal-title":"Methods Enzymol"},{"key":"key20200731033836_r90","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.2337\/diabetes.50.12.2641","article-title":"Loss of antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye diseases.","volume":"50","author":"Spranger","year":"2001","journal-title":"Diabetes"},{"key":"key20200731033836_r91","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0002-9394(02)01568-4","article-title":"Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy.","volume":"134","author":"Ogata","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key20200731033836_r92","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s00125-003-1040-9","article-title":"Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy.","volume":"46","author":"Boehm","year":"2003","journal-title":"Diabetologia"},{"key":"key20200731033836_r93","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2337\/diacare.23.1.80","article-title":"Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.","volume":"23","author":"Burgos","year":"2000","journal-title":"Diabetes Care"},{"key":"key20200731033836_r94","article-title":"Biomarkers in diabetic retinopathy and the therapeutic implications.","volume":"2013","author":"Zorena","year":"2013","journal-title":"Mediators of Inflammation Mediators Inflamm."},{"key":"key20200731033836_r95","first-page":"345","article-title":"Basic fibroblast growth factor mRNA, bFGF peptide and FGF receptor in epiretinal membranes of intraocular proliferative disorders (PVR and PDR).","volume":"20","author":"Hueber","year":"1996-1997","journal-title":"Int Ophthalmol"},{"key":"key20200731033836_r96","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/labinvest.3700121","article-title":"Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease.","volume":"84","author":"Hollborn","year":"2004","journal-title":"Lab Invest"},{"key":"key20200731033836_r97","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/oxfordjournals.jbchem.a021283","article-title":"Emerging multipotent aspects of hepatocyte growth factor.","volume":"119","author":"Matsumoto","year":"1996","journal-title":"J Biochem"},{"key":"key20200731033836_r98","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1136\/bjo.84.7.732","article-title":"Hepatocyte growth factor in vitreous and serum from patients with proliferative diabetic retinopathy.","volume":"84","author":"Cant\u00f3n","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"key20200731033836_r99","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1136\/bjo.83.7.834","article-title":"Comparison of the levels of hepatocyte growth factor and vascular endothelial growth factor in aqueous fluid and serum with grades of retinopathy in patients with diabetes mellitus.","volume":"83","author":"Shinoda","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"key20200731033836_r100","first-page":"1550","article-title":"Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy.","volume":"11","author":"Ma","year":"2018","journal-title":"Int J Ophthalmol"}],"container-title":["Biochemia medica"],"original-title":[],"link":[{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/30\/3\/10.11613\/BM.2020.030502\/fullArticle","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T08:11:52Z","timestamp":1667635912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biochemia-medica.com\/en\/journal\/30\/3\/10.11613\/BM.2020.030502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,12]]},"references-count":100,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,10,12]]},"published-print":{"date-parts":[[2020,10,15]]}},"URL":"https:\/\/doi.org\/10.11613\/bm.2020.030502","relation":{},"ISSN":["1846-7482","1330-0962"],"issn-type":[{"value":"1846-7482","type":"electronic"},{"value":"1330-0962","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10,12]]}}}